BIOMAT Database Logo BIOMAT Database Logo

Antibodies to HTLV-I in Sjögren's syndrome. 1995

X Mariette, and P Cherot, and D Cazals, and C Brocheriou, and J C Brouet, and F Agbalika

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012469 Salivary Glands Glands that secrete SALIVA in the MOUTH. There are three pairs of salivary glands (PAROTID GLAND; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND). Gland, Salivary,Glands, Salivary,Salivary Gland
D012859 Sjogren's Syndrome Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis. Sicca Syndrome,Sjogren Syndrome,Sjogrens Syndrome,Syndrome, Sicca,Syndrome, Sjogren's
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1
D015481 HTLV-I Antibodies Antibodies reactive with the HTLV-I ANTIGENS. ATLV Antibodies,Human T-Cell Leukemia Virus I Antibodies,Leukemia-Lymphoma Virus I Antibodies, Human T-Cell,T-Cell Leukemia Virus I Antibodies, Adult,T-Cell Leukemia Virus I Antibodies, Human,HTLV I Antibodies,Human T Cell Leukemia Virus I Antibodies,Leukemia Lymphoma Virus I Antibodies, Human T Cell,T Cell Leukemia Virus I Antibodies, Adult,T Cell Leukemia Virus I Antibodies, Human,Antibodies, ATLV,Antibodies, HTLV I,Antibodies, HTLV-I,I Antibodies, HTLV
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I
D015751 Genes, pol DNA sequences that form the coding region for retroviral enzymes including reverse transcriptase, protease, and endonuclease/integrase. "pol" is short for polymerase, the enzyme class of reverse transcriptase. pol Genes,pol Gene,Gene, pol
D015752 Genes, env DNA sequences that form the coding region for the viral envelope (env) proteins in retroviruses. The env genes contain a cis-acting RNA target sequence for the rev protein ( HIV rev-Responsive Element,env Genes,rev-Responsive Element,env Gene,Element, HIV rev-Responsive,Element, rev-Responsive,Elements, HIV rev-Responsive,Elements, rev-Responsive,Gene, env,HIV rev Responsive Element,HIV rev-Responsive Elements,rev Responsive Element,rev-Responsive Element, HIV,rev-Responsive Elements,rev-Responsive Elements, HIV
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D016355 Genes, pX DNA sequences that form the coding region for at least three proteins which regulate the expression of HUMAN T-LYMPHOTROPIC VIRUS 1 and HUMAN T-LYMPHOTROPIC VIRUS 2. The proteins are p21(x), p27(rex), and p40(tax). The tax (trans-activator x) and rex (regulator x) genes are part of pX but are in overlapping reading frames. X was the original designation for the sequences or region (at that time of unknown function) in the long open reading frame (lor) which is now called pX. Genes, rex,Genes, tax,HTLV-I rex Genes,HTLV-I tax Genes,HTLV-II rex Genes,HTLV-II tax Genes,pX Genes,rex Genes,tax Genes,Genes, lor,Gene, HTLV-I rex,Gene, HTLV-I tax,Gene, HTLV-II rex,Gene, HTLV-II tax,Gene, lor,Gene, pX,Gene, rex,Gene, tax,Genes, HTLV-I rex,Genes, HTLV-I tax,Genes, HTLV-II rex,Genes, HTLV-II tax,HTLV I rex Genes,HTLV I tax Genes,HTLV II rex Genes,HTLV II tax Genes,HTLV-I rex Gene,HTLV-I tax Gene,HTLV-II rex Gene,HTLV-II tax Gene,lor Gene,lor Genes,pX Gene,rex Gene,rex Gene, HTLV-I,rex Gene, HTLV-II,rex Genes, HTLV-I,rex Genes, HTLV-II,tax Gene,tax Gene, HTLV-I,tax Gene, HTLV-II,tax Genes, HTLV-I,tax Genes, HTLV-II

Related Publications

X Mariette, and P Cherot, and D Cazals, and C Brocheriou, and J C Brouet, and F Agbalika
Antibodies to HTLV-I in Sjögren's syndrome.
January 1995, Lancet (London, England),
X Mariette, and P Cherot, and D Cazals, and C Brocheriou, and J C Brouet, and F Agbalika
Antibodies to HTLV-I in Sjögren's syndrome.
January 1995, Lancet (London, England),
X Mariette, and P Cherot, and D Cazals, and C Brocheriou, and J C Brouet, and F Agbalika
Antibodies to HTLV-I in Sjögren's syndrome.
January 1995, Lancet (London, England),
X Mariette, and P Cherot, and D Cazals, and C Brocheriou, and J C Brouet, and F Agbalika
Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features.
June 1992, Annals of the rheumatic diseases,
X Mariette, and P Cherot, and D Cazals, and C Brocheriou, and J C Brouet, and F Agbalika
HTLV-I associated Sjögren's syndrome is aetiologically distinct from anti-centromere antibodies positive Sjögren's syndrome.
May 1999, Annals of the rheumatic diseases,
X Mariette, and P Cherot, and D Cazals, and C Brocheriou, and J C Brouet, and F Agbalika
[Sjögren's syndrome and HTLV-I myelopathy].
January 1996, Annales de medecine interne,
X Mariette, and P Cherot, and D Cazals, and C Brocheriou, and J C Brouet, and F Agbalika
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
October 1994, Lancet (London, England),
X Mariette, and P Cherot, and D Cazals, and C Brocheriou, and J C Brouet, and F Agbalika
HTLV-I associated uveitis, myelopathy, rheumatoid arthritis and Sjögren's syndrome.
December 1995, Arquivos de neuro-psiquiatria,
X Mariette, and P Cherot, and D Cazals, and C Brocheriou, and J C Brouet, and F Agbalika
[A case of HTLV-I associated myelopathy (HAM) with Sjögren's syndrome].
September 1989, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
X Mariette, and P Cherot, and D Cazals, and C Brocheriou, and J C Brouet, and F Agbalika
[HTLV-I infection in primary Sjögren's syndrome--epidemiological, clinical and virological studies].
October 1995, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!